
Overview
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere.
Dr. Crawford is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).
Dr. Crawford is board certified in American Board Of Internal Med, Internal Medicine , American Board Of Internal Med, Hematology/Oncology , and American Board Of Internal Med, Medical Oncology. He is actively involved in clinical research, co-authoring 4 peer reviewed articles. Dr. Crawford is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Crawford has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cancer Center
I am a medical oncologist who focuses on bone and soft tissue cancers called sarcomas. I love spending time with my patients. They often have a sense of awareness about their condition that’s truly unique and rewarding. I partner with each patient so they know the full set of options available for treatment and can make an informed decision about the approach that is best for them. I’ve wanted to pursue medicine for as long as I can remember. I find cancer fascinating because of its ability to evade the immune system. The body fails to recognize cancer as being foreign. When I am not at work, I love spending time with my family and enjoy long distance running. Dr. Riedel is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Desmoid Tumor, and Angiosarcoma. Dr. Riedel is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. Dr. Riedel is currently accepting new patients.
Duke Cancer Center Brain Tumor Clinic
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Friedman is board certified in American Board Of Pediatrics, General Pediatrics and American Board Of Pediatrics, Pediatric Hematology-Oncology. Dr. Friedman is currently accepting new patients.
Duke Cancer Center
I am a part of the thoracic oncology program. I work with patients who have cancers of the lung, which includes non-small cell lung cancer, small cell lung cancer, and mesothelioma. My focus is on clinical care, clinical trials, and developing new therapies for these diseases. When I first meet with a patient, I want them to understand what their diagnosis is, because there are actually multiple diagnoses of lung cancer and each are treated differently. Then I discuss with a patient whether they are a candidate for therapies such as molecular therapy or immunotherapy, and make sure they have a clear understanding of the treatment plan. There are some very promising new therapies for these diseases and we are fortunate to have those available to patients here at Duke. That’s one of the unique things we offer as an academic medical center. Dr. Stinchcombe is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery. Dr. Stinchcombe is board certified in American Board Of Internal Med, Medical Oncology. Dr. Stinchcombe is currently accepting new patients.
Duke Cancer Center Thoracic Clinic
Scott Antonia is an Oncologist practicing medicine in Durham, North Carolina. Dr. Antonia is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Antonia is board certified in American Board Of Internal Med, Medical Oncology. Dr. Antonia is currently accepting new patients.
Duke Cancer Center Genitourinary (GU) Clinic
I specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer. A cancer diagnosis is one of the scariest things that can happen to someone. For many of our patients, they don’t necessarily feel different or look different, but they are scared to death. The most important thing you can get from Duke is real understanding of your particular case and what your options are. Knowledge is so reassuring and empowering for patients, especially those recently diagnosed with cancer. When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. As the largest cancer center in North Carolina, Duke has great reputation and experience, which helps many patients chose Duke for their care. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case. Dr. George is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. George is currently accepting new patients.
Duke Cancer Center Thoracic Clinic
I realized during a biology class in college that I could use my interest in science to help make a difference in people’s lives. It drove my decision to pursue a career in medicine. I realized early in medical school that I wanted to spend my career trying to understand cancer, how to fight it and caring for patients who have it. As a medical oncologist with Duke Cancer Center, I specialize in cancers of the chest, including lung cancer and mesothelioma. Working closely with my patients, getting to know them personally and understanding their values and goals, allows me to develop individualized care and treatment plans for each one. The most rewarding part of my work is developing long term relationships with my patients and their families throughout their cancer journeys. I am motivated and inspired by how my patients live their lives everyday. Dr. Clarke is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Clarke is board certified in American Board Of Internal Med, Medical Oncology. Dr. Clarke is currently accepting new patients.
Frequently Asked Questions about Dr. Jeffrey A. Crawford
How do I make an appointment with Dr. Jeffrey A. Crawford?
You can book an appointment with Dr. Jeffrey A. Crawford by calling their office at 919-681-6900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jeffrey A. Crawford a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey A. Crawford is classified as an Distinguished expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jeffrey A. Crawford specialize in?
While Dr. Jeffrey A. Crawford is a Hematology Oncology, they have specific expertise in Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Jeffrey A. Crawford participate in research or clinical trials?
Yes. Dr. Jeffrey A. Crawford has published 4 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Jeffrey A. Crawford's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jeffrey A. Crawford accept my insurance?
Dr. Jeffrey A. Crawford accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-681-6900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Crawford isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Crawford isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Crawford isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Crawford isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Crawford isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Crawford isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Crawford isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Crawford isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Crawford isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Adult Soft Tissue SarcomaDr. Crawford isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorDr. Crawford isAdvanced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Crawford isAdvanced. Learn about Epithelioid Sarcoma.
- FibrosarcomaDr. Crawford isAdvanced. Learn about Fibrosarcoma.
- LiposarcomaDr. Crawford isAdvanced. Learn about Liposarcoma.
- MesenchymomaDr. Crawford isAdvanced. Learn about Mesenchymoma.
- MesotheliomaDr. Crawford isAdvanced. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Crawford isAdvanced. Learn about Metastatic Pleural Tumor.
- Myxoid LiposarcomaDr. Crawford isAdvanced. Learn about Myxoid Liposarcoma.
- Posterior Fossa TumorDr. Crawford isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Rhabdomyosarcoma EmbryonalDr. Crawford isAdvanced. Learn about Rhabdomyosarcoma Embryonal.
- Thymic Epithelial TumorDr. Crawford isAdvanced. Learn about Thymic Epithelial Tumor.
- Undifferentiated Pleomorphic SarcomaDr. Crawford isAdvanced. Learn about Undifferentiated Pleomorphic Sarcoma.
- Experienced
- Lung NodulesDr. Crawford isExperienced. Learn about Lung Nodules.
- Metastatic Brain TumorDr. Crawford isExperienced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Crawford isExperienced. Learn about Neuroendocrine Tumor.
- PlasmacytomaDr. Crawford isExperienced. Learn about Plasmacytoma.
- Polymorphous Low Grade AdenocarcinomaDr. Crawford isExperienced. Learn about Polymorphous Low Grade Adenocarcinoma.
- Sickle Cell DiseaseDr. Crawford isExperienced. Learn about Sickle Cell Disease.




